Abstract
Early diagnosis and treatment of acute cellular rejection (ACR) after intestinal transplantation (ITx) is challenging. We report the outcome of three patients: two presented mild ACR improved with steroids. One presented steroid-resistant severe rejection, improved after rabbit anti-thymocyte globulin (r-ATG), but unfortunately died for encephalitis caused by opportunistic infections.
MeSH terms
-
Adolescent
-
Anastomosis, Surgical
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antilymphocyte Serum / administration & dosage*
-
Basiliximab
-
Child
-
Daclizumab
-
Encephalitis / etiology
-
Fatal Outcome
-
Female
-
Graft Rejection / diagnosis*
-
Graft Rejection / drug therapy*
-
Humans
-
Immunoglobulin G / therapeutic use
-
Immunosuppressive Agents / administration & dosage*
-
Intestinal Diseases / surgery
-
Intestinal Volvulus / surgery
-
Intestines / transplantation*
-
Male
-
Nervous System Diseases / surgery
-
Recombinant Fusion Proteins / therapeutic use
-
Short Bowel Syndrome / surgery
-
Tacrolimus / administration & dosage
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antilymphocyte Serum
-
Immunoglobulin G
-
Immunosuppressive Agents
-
Recombinant Fusion Proteins
-
Basiliximab
-
Daclizumab
-
Tacrolimus
Supplementary concepts
-
Neuronal intestinal pseudoobstruction